Untreated Adult Acute Lymphoblastic Leukemia Completed Phase 1 / 2 Trials for Methotrexate (DB00563)

Indication	Status	Phase
DBCOND0029290 (Untreated Adult Acute Lymphoblastic Leukemia)	Completed	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00061945	Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia	Treatment	Acyclovir (DB00787) Alemtuzumab (DB00087) Allopurinol (DB00437) Asparaginase Escherichia coli (DB00023) Cyclophosphamide (DB00531) Cytarabine (DB00987) Daunorubicin (DB00694) Dexamethasone (DB01234) Filgrastim (DB00099) Imatinib (DB00619) Leucovorin (DB00650) Mercaptopurine (DB01033) Methotrexate (DB00563) Sulfamethoxazole (DB01015) Trimethoprim (DB00440) Vincristine (DB00541)